ARCH Venture Partners
Status
ACTIVE
Global HQ
Miami, United States
Countries of investment
- USA
Investment stages
- Series B
- Series C
Industries
- Health Tech
- Consumer Health
- Pharmaceuticals
- Biotech
- Health Tech
- Medical Services
About
ARCH Venture Partners focuses on catalyzing disruptive discoveries in BioTech and health Technology. ARCH is committed to building truly transformational companies by providing invaluable advice, expertise, and network to their entrepreneurs. Their investment philosophy includes forming strategic partnerships, fostering great science, and supporting amazing teams to prevent, detect, and cure disease.
ARCH Venture Partners focuses on catalyzing disruptive discoveries in BioTech and health Technology. ARCH is committed to building truly transformational companies by providing invaluable advice, expertise, and network to their entrepreneurs. Their investment philosophy includes forming strategic partnerships, fostering great science, and supporting amazing teams to prevent, detect, and cure disease.
Investment Thesis
ARCH Venture Partners focuses on investing in early stage companies with transformative technologies and innovative business models. Their investment thesis is centered on identifying and nurturing high potential startups that have the capability to create significant advancements in science and Technology. ARCH Venture Partners seeks to partner with visionary entrepreneurs and provide the resources needed to accelerate their growth and bring groundbreaking solutions to market.
Portfolio
Illumina
Alnylam Pharmaceuticals
Juno Therapeutics
Receptos
Agios
Sage Therapeutics
bluebird bio
Resilience
Codiak Therapeutics
Denali Therapeutics
Grail
Karuna Therapeutics
Beam
Lyell
Vir
Sana BioTech
Homology Medicines
Gossamer Bio
deCODE Genetics
Scholar Rock
Unity BioTech
Vividion Therapeutics
Carrick Therapeutics
Boundless Bio
Ahura Scientific
Caliper Life Sciences
Ikaria
Hua Medicine
Quanterix
Syros Pharmaceuticals
Twist Bioscience
Ultivue
Array BioPharma ‚¹